Influences of AT1 receptor blockade on tissue metabolism in obese men

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 290, Issue 1, 2006, Pages

  Boschmann, Michael ^a   Engeli, Stefan ^a   Adams, Frauke ^a   Franke, Gabriele ^a   Luft, Friedrich C ^a   Sharma, Arya M ^b   Jordan, Jens ^a  

^a FRANZ VOLHARD CLINIC   (Germany)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Adipose tissue; Angiotensin II; Insulin

Indexed keywords

ALCOHOL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN II; GLUCOSE; GLYCEROL; IRBESARTAN; LACTIC ACID; PLACEBO; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BIPHENYL DERIVATIVE; ISOPRENALINE; PYRUVIC ACID; TETRAZOLE DERIVATIVE;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; GLYCOLYSIS; HUMAN; LIPID METABOLISM; LIPOLYSIS; MALE; MUSCLE METABOLISM; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TISSUE BLOOD FLOW; TISSUE METABOLISM; DRUG EFFECT; ENERGY METABOLISM; METABOLISM; MICRODIALYSIS; SKELETAL MUSCLE;

ADIPOSE TISSUE; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BIPHENYL COMPOUNDS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; ETHANOL; GLYCEROL; HUMANS; ISOPROTERENOL; LACTIC ACID; MALE; MICRODIALYSIS; MUSCLE, SKELETAL; OBESITY; PYRUVIC ACID; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES;

EID: 33644844387     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00341.2005     Document Type: Article

References (18)

1. Boschmann M, Jordan J, Adams F, Christensen NJ, Tank J, Franke G, Stoffels M, Sharma AM, Luft FC, and Klaus S. Tissue-specific response to interstitial angiotensin II in humans. Hypertension 41: 37-41, 2003.
2. Boschmann M, Jordan J, Schmidt S, Adams F, Luft FC, and Klaus S. Gender-specific response to interstitial angiotensin II in human white adipose tissue. Horm Metab Res 34: 726-730, 2002.
3. Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, and Cassis LA. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287: R943-R949, 2004.
4. Boustany CM, Brown DR, Randall DC, and Cassis LA. AT1 receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity. Am J Physiol Regul Integr Comp Physiol 289: R181-R186, 2005.
5. Cabassi A, Coghi P, Govoni P, Barouhiel E, Speroni E, Cavazzini S, Cantoni AM, Scandroglio R, and Fiaccadori E. Sympathetic modulation by carvedilol and losartan reduces angiotensin II-mediated lipolysis in subcutaneous and visceral fat. J Clin Endocrinol Metab 90: 2888-2897, 2005.
6. Campbell WB and Jackson EK. Modulation of adrenergic transmission by angiotensins in the perfused rat mesentery. Am J Physiol Heart Circ Physiol 236: H211-H217, 1979.
7. Cassis LA and Dwoskin LP. Presynaptic modulation of neurotransmitter release by endogenous angiotensin II in brown adipose tissue. J Neural Transm Suppl 34: 129-137, 1991.
8. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, and Sharma AM. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45: 356-362, 2005.
9. Frossard M, Joukhadar C, Steffen G, Schmid R, Eichler HG, and Muller M. Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor inhibition on transcapillary glucose transport in humans. Life Sci 66: L147-L154, 2000.
10. Goossens GH, Blaak EE, Saris WH, and van Baak MA. Angiotensin II-induced effects on adipose and skeletal muscle tissue blood flow and lipolysis in normal-weight and obese subjects. J Clin Endocrinol Metab 89: 2690-2696, 2004.
11. Gorzelniak K, Engeli S, Janke J, Luft FC, and Sharma AM. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 20: 965-973, 2002.
12. Hickner RC, Ekelund U, Mellander S, Ungerstedt U, and Henriksson J. Muscle blood flow in cats: comparison of microdialysis ethanol technique with direct measurement. J Appl Physiol 79: 638-647, 1995.
13. Jordan J, Tank J, Stoffels M, Franke G, Christensen NJ, Luft FC, and Boschmann M. Interaction between β-adrenergic receptor stimulation and nitric oxide release on tissue perfusion and metabolism. J Clin Endocrinol Metab 86: 2803-2810, 2001.
14. Ogihara T, Asano T, Ando K, Chiba Y, Sakoda H, Anai M, Shojima N, Ono H, Onishi Y, Fujishiro M, Katagiri H, Fukushima Y, Kikuchi M, Noguchi N, Aburatani H, Komuro I, and Fujita T. Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling. Hypertension 40: 872-879, 2002.
15. Scheen AJ. Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomised clinical trials. Diabetes Metab 30: 487-496, 2004.
16. Tuck ML, Sowers J, Dornfeld L, Kledzik G, and Maxwell M. The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 304: 930-933, 1981.
17. Ungerstedt U. Microdialysis in normal and injured brain. In: Physiology, Stress, and Malnutrition, edited by Kinney JM and Tucker HN. New York: Lippincott-Raven, 1997, p. 361-374.
18. van den Meiracker AH, Admiraal PJ, Janssen JA, Kroodsma JM, de Ronde WA, Boomsma F, Sissmann J, Blankestijn PJ, Mulder PG, and Man In't Veld AJ and Schalekamp MADH. Hemodynamic and biochemical effects of the AT1 receptor antagonist irbesartan in hypertension. Hypertension 25: 22-29, 1995.